Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
May 2012
Features
Evaluation of an Adult Insulin Infusion Protocol At an Academic Medical Center
After a more lenient insulin protocol was implemented at the authors’ institution, patients’ blood glucose values stayed within the target range for a shorter time than with the former (stricter) protocol. Fewer episodes of hypoglycemia occurred with the newer protocol, but rates of severe hypoglycemia were similar with both protocols.
Katerina I. Petrov, PharmD; Tammy L. Burns, PharmD, BCPS; and Andjela Drincic, MD
Drug Use Evaluation of Moxifloxacin (Avelox) Using a Hand-Held Electronic Device At a Canadian Teaching Hospital
Seeking to determine whether moxifloxacin was being overused as a first-line therapy in the hospital, the authors found a high rate of appropriate use. Personal digital assistants (PDAs) were helpful, easy to use, and superior to paper methods in collecting data for their DUE review.
Jennifer A. E. Samilski, MD; Tim T. Y. Lau, PharmD, ACPR; Dean H. T. Elbe, PharmD, ACPR, BCPP; Amneet K. Aulakh, PharmD, ACPR; and Eric M. C. Lun, PharmD, ACPR
FDA Considers a New Paradigm For Over-the-Counter Medications
More Power—but More Burdens—for Pharmacists and Pharmacies
The FDA is debating whether to switch more prescription drugs to a new over-the-counter category and whether a drug could be classified as both a prescription and a nonprescription product. If the FDA approves this paradigm, pharmacists and pharmacies would have important roles to play.
Stephen Barlas
Meeting Highlights
2012 American College of Cardiology, 61st Annual Scientific Session & Expo
Topics include immediate-use glucose, insulin, and potassium for cardiac protection; vorapaxar to prevent atherothrombosis; and rivaroxaban for the treatment of pulmonary embolism. Interactions with dietary supplements are also reviewed.
Walter Alexander
Departments
Medication Errors
Managing Visits From Pharmaceutical Sales Representatives
Implementing policies for pharmaceutical sales representatives who visit hospitals
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Bar-Code Rule for Medical Devices May Be Imminent
Benefits and shortcomings of a national identification system for tracking medical devices
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Axitinib (Inlyta) for renal cell carcinoma; tafluprost (Zioptan) to reduce intraocular pressure; and lucinactant (Surfaxin) to prevent respiratory distress syndrome in premature infants
Marvin M. Goldenberg, PhD, RPh, MS
Drug Forecast
Fidaxomicin (Dificid), a Novel Oral Macrocyclic Antibacterial Agent For the Treatment of Clostridium difficile–Associated Diarrhea in Adults
Fidaxomicin (Dificid) for Clostridium difficile–associated diarrhea
Martin Paspe Cruz, PharmD, CGP, BCPP
